CSIMarket Company Name, Ticker, Customers, else..


Abbott Laboratories  (NYSE: ABT)
Other Ticker:  
 

Abbott Laboratories

ABT's Fundamental analysis



Looking into Abbott Laboratories growth rates, revenue grew by 7.16 % in IV. Quarter 2024 from the same quarter a year ago. Ranking at No. 663

Major Pharmaceutical Preparations industry recorded growth of revenues by 11.85 %

Abbott Laboratories's net income grew by 478.98 % in IV. Quarter 2024 year on year, above company average,

• More on ABT's Growth


Abbott Laboratories
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Abbott Laboratories PEG ratio is at 0.12 Company is currently trading with Price to Cash flow multiple of 313.93 in trailing twelve-month period.
Company
16.79
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 5.39.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.


• More on ABT's Valuation
 
 Total Debt (Millions $) 16,846
 Dividend TTM ($) 2.19 $
 Dividend Yield TTM (%) 1.69 %
 Revenue/Employee (TTM) $ 367,982
 Net Income/Employee (TTM) $ 117,561
 Receivable Turnover (TTM) 6.76
 Tangible Book Value (Per Share $) 2.46

Abbott Laboratories
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Abbott Laboratories PEG ratio is at 0.12 Company is currently trading with Price to Cash flow multiple of 313.93 in trailing twelve-month period.
Company
16.79
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 5.39.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.

Abbott Laboratories Price to Book Ratio is at 6.04 lower than Industry Avg. of 79.76. and higher than S&P 500 Avg. of 0.01

• More on ABT's Valuation

•  Market Capitalization (Millions $) 226,027
•  Shares Outstanding (Millions) 1,754
•  Employees 114,000
•  Revenues (TTM) (Millions $) 41,950
•  Net Income (TTM) (Millions $) 13,402
•  Cash Flow (TTM) (Millions $) 720
•  Capital Exp. (TTM) (Millions $) -2,207
•  Total Debt (Millions $) 16,846
•  Dividend TTM ($) 2.19 $
•  Dividend Yield TTM (%) 1.69 %
•  Revenue/Employee (TTM) $ 367,982
•  Net Income/Employee(TTM) $ 117,561
•  Receivable Turnover Ratio (TTM) 6.76
•  Tangible Book Value (Per Share $) 2.46

•  Market Capitalization (Millions $) 226,027
•  Shares Outstanding (Millions) 1,754
•  Employees 114,000
•  Revenues (TTM) (Millions $) 41,950
•  Net Income (TTM) (Millions $) 13,402
•  Cash Flow (TTM) (Millions $) 720
•  Capital Exp. (TTM) (Millions $) -2,207


    ABT's Profitability Comparisons
Abbott Laboratories faced margin deterioration, primarily through cost control. Operating Margin fell in IV. Quarter 2024 to 17.41 % from 17.48 % in III. Quarter.

Abbott Laboratories net profit margin of 84.1 % is currently ranking no. 6 in Major Pharmaceutical Preparations industry, ranking no. 21 in Healthcare sector and number 97 in S&P 500.


Profitability by Segment
Total 15.48 %



  Ratio
•   Capital Ratio (MRQ) 1.64
•  Total Debt to Equity (MRQ) 0.45
•  Tangible Leverage Ratio (MRQ) 6.76
•  Asset Turnover Ratio (TTM) 0.56
•  Inventory Turnover Ratio (TTM) 2.94



Abbott Laboratories faced margin deterioration, primarily through cost control. Operating Margin fell in IV. Quarter 2024 to 17.41 % from 17.48 % in III. Quarter.

Abbott Laboratories net profit margin of 84.1 % is currently ranking no. 6 in Major Pharmaceutical Preparations industry, ranking no. 21 in Healthcare sector and number 97 in S&P 500.

• More on ABT's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com